Novyra Pharmachem Limited (BOM:519353)
India flag India · Delayed Price · Currency is INR
10.14
0.00 (0.00%)
At close: Sep 10, 2026

Novyra Pharmachem Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
649337216029
Market Cap Growth
84.94%154.16%76.35%-65.57%107.71%-12.07%
Enterprise Value
629035205928
Last Close Price
10.1414.975.893.349.704.67

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
----519.54855.13
PS Ratio
3.5188.87--40.0819.30
PB Ratio
10.3214.910.610.350.990.48
P/OCF Ratio
----43.50-

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
3.4186.32--39.6018.79
EV/EBITDA Ratio
----131.88-
EV/EBIT Ratio
----227.84-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.28-0.28-0.04-0.01-0.04-0.01
Net Debt / EBITDA Ratio
0.030.038.750.61-4.924.99
Asset Turnover
-0.03--0.020.02
Quick Ratio
-0.221.812.446.553.87
Current Ratio
-0.861.812.516.664.36
Return on Equity (ROE)
--162.40%-1.07%-2.65%0.19%0.06%
Return on Assets (ROA)
--87.66%-0.65%-1.61%0.26%-0.36%
Return on Invested Capital (ROIC)
-865.76%-162.40%-1.06%-2.65%0.15%-0.49%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-83.91%-57.92%-1.74%-7.70%0.19%0.12%
Buyback Yield / Dilution
21.25%--2.14%---